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A B S T R A C T
It is thought that during immobilization enzymes, as dynamic biomolecules, may become distorted and this may
alter their catalytic properties. However, the eﬀects of diﬀerent immobilization strategies on enzyme rigidity or
ﬂexibility and their consequences in speciﬁcity and stereochemistry at large scale has not been yet clearly
evaluated and understood. This was here investigated by using as model an ester hydrolase, isolated from a
bacterium inhabiting a karstic lake, with broad substrate spectrum (72 esters being converted; 61.5 U mg−1 for
glyceryl tripropionate) but initially non-enantiospeciﬁc. We found that the enzyme (7 nm×4.4 nm × 4.2 nm)
could be eﬃciently ionic exchanged inside the pores (9.3 nm under dry conditions) of amino-functionalized
ordered mesoporous material (NH2-SBA-15), achieving a protein load of 48mg g−1, and a speciﬁc activity of
4.5 ± 0.1 U mg−1. When the enzyme was site-directed immobilized through His interaction with an im-
mobilized cationon the surface of two types of magnetic micro-particles through hexahistidine-tags, protein
loads up to 10.2 μg g−1 and speciﬁc activities of up to 29.9 ± 0.3 U mg−1, were obtained. We found that
ionically exchanged enzyme inside pores of NH2-SBA-15 drastically narrowed the substrate range (17 esters), to
an extent much higher than ionically exchanged enzyme on the surface of magnetic micro-particles (up to 61
esters). This is attributed to diﬀerences in surface chemistry, particle size, and substrate accessibility to the active
site tunnel. Our results also suggested, for the ﬁrst time, that immobilization of enzymes in pores of similar size
may alter the enzyme structures and produce enzyme active centers with diﬀerent conﬁguration which promote
stereochemical conversions in a manner diﬀerent to those arising from surface immobilization, where the
strength of the ionic exchange also has an inﬂuence. This was shown by demonstrating that when the enzyme
was introduced inside pores with a diameter (under dry conditions) slightly higher than that of the enzyme
crystal structure a biocatalyst enantiospeciﬁc for ethyl (R)-4-chloro-3-hydroxybutyrate was produced, a feature
not found when using wider pores. By contrast, immobilization on the surface of ferromagnetic microparticles
produced selective biocatalysts for methyl (S)-(+)-mandelate or methyl (S)-lactate depending on the functio-
nalization. This study illustrates the beneﬁts of extensive analysis of the substrate spectra to better understand
the eﬀects of diﬀerent immobilization strategies on enzyme ﬂexibility/rigidity, as well as substrate speciﬁcity
and stereochemistry. Our results will help to design tunable materials and interfaces for a controlled manip-
ulation of speciﬁcity and to transform non-enantiospeciﬁc enzymes into stereo-chemically substrate promiscuous
biocatalysts capable of converting multiple chiral molecules.
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1. Introduction
Enzymes are delicate organic catalysts that need to be stabilized to
survive a range of challenging conditions typically used in industrial
processes. Multiple immobilization methods and materials have been
successfully employed to generate stabilized biocatalysts [1–4], but the
most eﬃcient immobilization protocol and materials may be selected
aiming at a balance between activity, speciﬁcity, stability, and costs
[5]. Besides most used carriers such as (epoxy)acrylic resins and
agarose and widely used nanoparticles such as chitosan and nano-
ﬂowers [6], outstanding recent examples for enzyme immobilization
and stabilization included biomimetic silica supports [7], mesos-
tructured onion-like silica [8], hybrid macroporous foams synthesized
via an integrative chemistry synthetic pathway [9], superparamagnetic
silica/iron oxide nanocomposites with mesostructured porosity [10],
maghemite (γ-Fe2O3) nanoparticles functionalized with a reactive
multifunctional polymer [11], dendronized polymer and mesoporous
silica nanoparticles [12], carbon nanotubes and polymers [13], epoxy-
activated carriers [14], borosilicate [15], hematite nanoparticles [16],
phyto-inspired silica nanowires [17], and materials with bioinspired
coatings [18], to cite some. These studies exemplify the large interest in
designing new and more eﬃcient carriers for enzyme immobilization,
the comparative analysis of which at large, in relation to their eﬀect in
enzyme substrate speciﬁcity (including enantiospeciﬁcity), may de-
serve further interest.
A major advance in the last decade has been the development of
enzyme encapsulation in ordered mesoporous materials, because of
their high speciﬁc surface area and pore volume, their highly uniform
and tunable pore sizes, and the possibility to create micropores inter-
connecting mesopores and to control their morphology; they are also
thermally, mechanically and chemically stable [5,19–23]. Various
proteins have been successfully immobilized on mesoporous materials,
including, non-catalytic proteins, oxidoreductases, hydrolases, lyases
and isomerases [5,24–41]. Enzymes immobilized in conﬁned macro-
molecular environments where the surface and volume of the conﬁned
environment can be controlled, are suggested to constitute optimal
enzymatic nanoreactors [19,42,43]. Their surface can be grafted with
diﬀerent functionalities [23,17,18], a property particularly interesting
to allow, for example, the ionic exchange enzyme encapsulation in
amino-functionalized ordered mesoporous materials. This development
led to an increased enzyme loading (up to 187mg g−1 of catalyst) by
simply adjusting synthetic conditions of the siliceous material for the
obtaining of pores large enough to permit enzyme entrance and diﬀu-
sion through the pore channels [17,18]. As example, mesoporous ma-
terials with pore diameters as low as 3–10 nm and also tailored between
3–30 nm have been synthesized [for examples see ref.
19,23,25,28,29,31], and enzymes with sizes such as 6.1 nm×5.0
nm×4.9 nm [20] have been immobilized in the pores. In these ordered
structures the enzyme is immobilized by electrostatic interactions with
limited diﬀusional restrictions and low enzyme modiﬁcation, typically
occurring after covalent binding or crosslinking [44]. This ion exchange
of the enzyme on the support, was demonstrated to minimize leaching
and maximize activity and stability of the biocatalyst [17,18].
Compared to free enzyme in solution, immobilization on a surface
often hinders the free movement of the enzyme, although it is believed
that the enzyme is positioned in an environment where the inherent
ﬂexibility is high [45]. The conﬁnement in the pores of mesoporous
materials is also thought to hinder the free movement of enzyme, but to
what extent the diﬀerences in movement and ﬂexibility aﬀects enzyme
properties remains to be elucidated. In this direction, it is only supposed
that larger substrates may be preferably hydrolyzed by enzymes im-
mobilized on the external surface or at the entrance of the channels of
mesoporous materials because of substrate diﬀusional and enzyme or-
ientation issues, as it was demonstrated by modelling predictions [46]
and also using a lipase when tested with small (tributyrin) and large
(triolein) substrates [47]. However, a general overview about how
enzyme immobilization inside pores aﬀects substrate speciﬁcity com-
pared to the free enzyme and surface-immobilized enzyme remains to
be established. Indeed, diverse surface immobilization methods have
been shown to preserve activity level and, most importantly, to even
create enantiospeciﬁc enzymes such as lipases [for example see ref.
48–50]. These, and other studies, have been performed using a re-
stricted set of molecules and a comparative analysis at large is lacking.
Here, we examine the substrate range and enantiospeciﬁcity of a
target enzyme by using as supports, an amino-functionalized ordered
mesoporous material (NH2-SBA-15) allowing non-covalent enzyme
immobilization inside pores and two types of magnetic microparticles
for non-covalent surface immobilization. Particularly, agarose-coated
ferromagnetic core-shell microparticles with a nitrilotetracetic acid
(NTA) tetradentate ligand, and polyvinyl alcohol microparticles em-
bedded with magnetite and grafted with an iminodiacetic acid (IDA)
tridentate ligand. Both particles were Ni2+-activated and thus can be
used for puriﬁcation and immobilization given the aﬃnity for hex-
ahistidine-tags. As model enzyme, a serine ester hydrolase isolated from
the metagenomic DNA of microbial communities inhabiting a karstic
lake [51], referred to as EH1, with a typical α/β hydrolase fold as a
model. Its structure was recently solved (PDB code 5JD4) [51,52], and
in a recent study it was identiﬁed as one of the ester hydrolases with
broader substrate spectrum among a total of 147 when tested with a set
of 96 chemically and structurally diﬀerent esters [51]. The active site
(catalytic triad: Ser161, Asp256 and His286; oxyanion hole: Gly88,
Gly89 and Gly90) supports the hydrolysis of a broad range of 72 esters,
with vinyl butyrate (200.7 ± 0.4 U mg−1) and phenyl propionate
(198.7 ± 0.9 U mg−1) serving as the best substrates (Table S1). Being
highly promiscuous in terms of substrate scope, EH1 is not en-
antiospeciﬁc; thus the apparent enantiospeciﬁcity (Eapp) factor calcu-
lated as the ratio of speciﬁc activities for 14 chiral esters when pure
stereoisomers were tested separately [53] was below 25, a value above
which ester hydrolases begin to have practical value [54]. Based on
these considerations, EH1 may be then considered as an ester hydrolase
with prominent substrate promiscuity but with limited practical use due
to the low stereospeciﬁcity. Because substrate promiscuity and en-
antiospeciﬁcity are two appreciated properties when combined in a
single biocatalyst, which is rare in nature within esterases [54], we
evaluated whether both properties can be tailored by employing three
immobilization strategies.
To the best of our knowledge, detailed analysis of the substrate
spectrum and interpretation of the data provides, for the ﬁrst time, new
insights into the contribution of chemical, physical, and ﬂexibility
constrains to the catalytic capacity of biocatalysts prepared by these
immobilization methods. We would like to highlight that the eﬀect of
immobilization on enzyme ﬂexibility has been previously studied, for
example, by increasing the number of bonds by which the enzyme is
linked to the surface of carriers [48–50]. It is though that this increases
enzyme rigidity and in turn has a consequence in promoting enzyme
stability and activity when tested over a speciﬁc set of substrates
[48–50]. The novelty of this study is that through an analysis of the
substrate speciﬁcity with a very broad spectrum of molecules, and 3
diﬀerent immobilization techniques, we were able to demonstrate that
each polymeric carrier induced diﬀerent ﬂexibility and rigidity con-
straints to the enzyme with distinct eﬀects on speciﬁcity and, most
importantly, enantiospeciﬁcity, which can be also controlled.
2. Experimental section
2.1. Chemicals and EH1 protein source
All chemicals used for enzymatic tests were of the purest grade
available and were purchased from sources described elsewhere [51].
The isolation of the enzyme EH1, available in the expression plasmid
pET46 Ek/LIC and Escherichia coli BL21 as a host, was reported pre-
viously [51,52].
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2.2. Gene expression and protein puriﬁcation
Expression of the gene encoding the N-terminally hexahistidine-
tagged enzyme and puriﬁcation were performed as previously de-
scribed [51,52]. Purity was assessed as> 98% using SDS-PAGE analysis
in a Mini PROTEAN electrophoresis system (Bio-Rad) [55]. The protein
concentration was determined according to Bradford assay with bovine
serum albumin as a standard [56].
2.3. Synthesis and characterization of the mesostructured silica support and
EH1 immobilization
Mesoporous silica with a periodic arrangement of uniform-diameter
pore channels (SBA-15 mesostructure) was synthesized according to the
method reported by Linton and Alfredsson [57]. A 2.5 wt% aqueous
solution of Pluronic PE-10400 (BASF) surfactant was prepared by
carefully dissolving this compound in a 1.6M HCl solution, at 35 °C, in
a closed polypropylene container kept under magnetic stirring for 2 h.
Tetramethyl orthosilicate (TMOS, 98%, Aldrich) was added to this so-
lution (3.8 g TMOS in 100 g of surfactant solution) and the mixture kept
at 55 °C for 20 h under magnetic stirring. The white solid product
formed was aged in the mother liquor at 75 °C for 24 h without stirring.
Finally, the solid was ﬁltered oﬀ, washed with absolute ethanol (Pan-
reac) and calcined in air in a muﬄe furnace at 550 °C for 6 h using a
2 °Cmin−1 heating ramp. The white powder obtained is labelled “SBA-
15”.
Powder X-ray diﬀraction (XRD) pattern of SBA-15 silica (Fig. 1)
were recorded at low angle (0.4-6°, step size 0.0167°) with a PANaly-
tical X’Pert Pro diﬀractometer using CuKα radiation with a nickel ﬁlter.
The pattern conﬁrms that the pore channels arrangement exhibits
p6mm hexagonal symmetry. It shows an intense peak at a 2θ angle of
0.9° corresponding to the d100 spacing and two weak reﬂections at 2θ
close to 1.5° and 1.7°, assigned to the d110 and d200 spacing, respec-
tively. From these data, the calculated unit-cell lattice parameter a0 is
11.3 nm. Note that the unit-cell lattice parameter a0 corresponds to the
distance between the centers of two neighboring cylindrical pore
channels (that is, the sum of the pore diameter and of the width of the
silica pore wall that separates two channels).
Scanning electron microscopy (SEM) images were recorded using a
FEI Nova NanoSEM 230 FE-SEM microscope equipped with vCD de-
tector. These images show (Fig. 2, left) the plate-like shape of silica
particles. Platelets were several microns wide and their thickness was
close to 200 nm. Transmission electron microscopy (TEM) images (ob-
tained with a JEOL JEM-2100 electron microscope operated at 200 kV)
showed (Fig. 2, right) that the mesopore channels exhibit a long-range
2D hexagonal arrangement, in agreement with XRD data, and that these
channels run parallel to the short axis of the platelets.
Nitrogen adsorption-desorption isotherm of SBA-15 silica (Fig. 3)
was acquired at 77 K with a Micromeritics ASAP 2420 sorptometer.
Prior to analysis, the sample was degassed at 623 K for 16 h. The iso-
therm obtained is of the type IVa according to 2015 IUPAC classiﬁca-
tion [58]. This type of isotherm shows a steep increase of the adsorbed
volume (that takes place at a relative pressure around 0.7 in the iso-
therm plotted in Fig. 3), due to capillary condensation in mesopores,
together with a hysteresis loop that is consistent with the presence of
cylindrical mesopores. Pore size distribution (Fig. 3, inset) was obtained
from the adsorption data using the methods of non-local density func-
tional theory (NLDFT) with the kernel function for oxide materials with
cylindrical pores [59,60]. The narrow distribution obtained indicates
that the dried mesoporous silica possesses pore channels with a highly
uniform diameter close to 9.3 nm. DFT calculations also indicated that
mesopores account for a total volume of 0.44 cm3 g−1 and that the
sample exhibits some micro-porosity (as expected for SBA-15 silica)
accounting for an additional volume of 0.1 cm3 g−1.
The SBA-15 silica sample was functionalized with aminopropyl
groups by grafting with an alkoxysilane. The silica powder (0.833 g)
was placed inside a round bottom ﬂask and dried overnight under va-
cuum (ca. 10−2 mbar) at 80 °C. Then, 50 mL of toluene (anhydrous,
99.8%, Sigma-Aldrich) were added to the ﬂask and the solid kept in
suspension with magnetic stirring under dry nitrogen atmosphere. To
this suspension, 1.0 mL of 3-aminopropyl)triethoxysilane (APTES, 99%,
Aldrich) was added (equivalent to 5mmol alkoxysilane per gram of
silica) and the mixture kept under reﬂux for 24 h. The solid was ﬁnally
ﬁltered oﬀ and washed with dry toluene and acetone. The content of
amino groups in the functionalized sample was determined to be
1.0 mmol g−1, as measured by CHN elemental analysis using a LECO
CHNS-932 equipment. This sample, labelled “NH2-SBA-15”, was used as
support for immobilization of EH1.
Brieﬂy, a total of 0.96mL of esterase solution (5mgmL−1) was
added to 10.04mL of 40mM HEPES buﬀer pH 7.0. Once dissolved,
100mg NH2-SBA-15 silica were added to 10mL of this solution.
Catalytic activity of the protein solution before immobilization was
measured using p-nitrophenyl acetate (pNP-acetate) as substrate as
described previously [52]. Immobilization was allowed to proceed at
diﬀerent intervals after which the catalytic activity was evaluated in the
supernatant and on the mesoporous silica (prior re-suspension in HEPES
(40mM, pH 7.0)) previously separated by centrifugation (13000 rpm,
room temperature, 1.5 min), and compared to the activity of the initial
esterase solution. The immobilization proceeded until the activity of the
supernatant was constant, which indicated full enzyme immobilization.
Then, the suspension was ﬁltered using sintered glass funnel, washed
with HEPES (40mM, pH 7.0), and vacuum-dried. The speciﬁc activity
of the immobilized enzyme was evaluated by quantifying the total units
of esterase activity (measured using pNP-acetate as substrate) at the
beginning of the experiment and the total units of the immobilized
biocatalyst (tested using 9.4mg of the biocatalyst re-suspended in 1mL
HEPES buﬀer, pH 7.0), as reported previously [52]. Under these con-
ditions, after 48 h, only 4% of the initial activity remained in the su-
pernatant and the enzyme loading obtained was of 48mg esterase per
gram of NH2-SBA-15 (or 96% total protein being immobilized) after
calculation of protein concentrations according to Bradford assay with
bovine serum albumin as the standard [56].
Fig. 4 summarizes the protocol used for the synthesis of the me-
sostructured silica support and EH1 immobilization, performed at pH
7.0, at which the amino groups of the support are positively charged
and the net charge of the enzyme is negative. Additional comments on
enzyme immobilization kinetics is provided in the Supporting In-
formation.
Fig. 1. XRD pattern of SBA-15 silica.
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2.4. EH1 immobilization on magnetic microparticles
Two types of commercial (PerkenElmer LAS, Rodgau, Germany)
magnetic microparticles with diﬀerentiated structural, chemical and
physical properties were used for surface immobilization of the enzyme.
The ﬁrst one is based on a N-hydroxysuccinimidyl (NHS) ester modiﬁed
polyvinyl alcohol (PVA) network with embedded magnetite (M)
(http://www.chemagen.com/magneticbeads.html) with a diameter size
range of 1–5 μm. The polymeric shell is chemically modiﬁed with the
iminodiacetic acid (IDA) tridentate ligand, which is eventually used for
enzyme immobilization. These beads, herein referred to as M-PVA-
IDA@Ni, were activated with NiSO4 prior to being used to capture His-
tagged proteins. The second type of microparticles, referred to as M-Ag-
NTA@Ni, is fabricated by coating a ferromagnetic core with 6% of
crosslinked agarose (http://www.cube-biotech.com/s-products/
magnetic-beads/his-aﬃnity-magbeads/ni-nta-magbeads). These ready-
to-use Ni-activated particles possess signiﬁcantly larger dimensions
(25–30 μm), and bear nitrilotetracetic acid (NTA) tetradentate ligand as
chelating agent instead of IDA. The characteristics of the magnetic
particles, which are commercially available, are described in https://
cube-biotech.com/his-aﬃnity-puriﬁcation-guide. The particles are
Ni2+-activated and thus can be used for protein puriﬁcation given the
aﬃnity for hexahistidine-tags. In our study we used these carriers for
site-directed immobilization by capturing His-tagged proteins though
Ni2+ which is diﬀerentially incorporated to the particles, as described
above. We would like to mention that after immobilization via the
hexahistidine-tags, it is possible that other groups others than His in-
teract with the metal, or that some ion exchange may occur. The same
enzyme immobilization protocol was used for both sorts of supports.
Shortly, particles (50 μL; delivered as 25% particle suspensions) were
retained by a magnet and the solution was decanted; after a careful
removal of the supernatant the pellet was washed twice with sodium
phosphate buﬀer (30mM, pH 8.0) and mixed afterwards with the en-
zyme solution (600 μL, 1.0mgmL−1) in the same buﬀer. Microparticles
were stirred until they were fully suspended. Upon incubation for 2 h at
room temperature, the particles were once again retained by a magnet
and the solution decanted and washed by repeating the procedure de-
scribed above 3 times. Final enzyme-particle conjugates were sus-
pended in 200 μL of sodium phosphate buﬀer (30mM, pH 8.0) buﬀer
and used directly for activity measurements. Protein loading was cal-
culated by measuring the diﬀerence in protein concentration before and
after the immobilization experiment. Hence, protein concentrations of
≈ 0.64 g L−1 (or≈ 10.2 μg g−1) for M-PVA-IDA@Ni and≈ 0.52 g L−1
(or ≈ 8.3 μg g−1) for M-Ag-NTA@Ni were measured.
Fig. 5 summarizes the protocol used for EH1 immobilization on
magnetic microparticles. The EH1 employed was initially designed with
a His-tag for puriﬁcation purposes and could therefore be directly
employed for immobilization.
Fig. 2. Left: SEM micrograph showing the plate-like morphology of SBA-15 silica particles. Right: TEM image recorded in the direction of the axis of SBA-15
mesopore channels. For experimental details see Experimental Section.
Fig. 3. Nitrogen adsorption-desorption isotherm at 77 K of silica SBA-15. Full
symbols correspond to the adsorption branch and empty symbols to desorption.
The inset shows the pore-size distribution calculated by NLDFT. The Nitrogen
adsorption-desorption isotherm for NH2-SBA-15 is not shown but it is estimated
that the grafting of aminopropyl groups on the surface of pores will decrease the
pore width by ca. 2 nm.
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2.5. Ester bond hydrolysis activity assessment
Hydrolytic activity of free and immobilized preparations was as-
sayed using a pH indicator assay at 550 nm using 96 structurally diverse
esters in 384-well plates as previously described [51,52]. Brieﬂy, re-
actions (total volume of 44 μL) were performed in 5mM N-(2-hydro-
xyethyl)piperazine-N’-(3-propanesulfonic acid) buﬀer (pH 8.0) con-
taining 1.14mgmL−1 of each ester and 0.45mM phenol red (used as
pH indicator), and 2 μL of immobilized preparation (from a 10mg solid
particle per mL in 40mM HEPES buﬀer pH 7.0) or free enzyme solution
(1mgmL−1) were immediately added to each well using an Eppendorf
Repeater M4 pipette (Eppendorf, Hamburg, Germany). The total reac-
tion volume was 44 μL. Note that a ﬁxed concentration of 1.14mg
mL−1 of each ester was used; this corresponds to an ester concentration
ranging from 1.28 to 13.2mM, depending on the ester [51], con-
centrations that in all cases were above the Km values for the target
enzyme [51], so that the substrate saturation was guarantee for activity
tests. After incubation at 30 °C and 150 rpm in a Synergy HT Multi-
Mode Microplate Reader, ester hydrolysis was measured spectro-
photometrically in continuous mode at 550 nm over 24 h. One unit (U)
of enzyme activity was deﬁned as the amount of free enzyme or enzyme
bound to the carrier required to transform 1 μmol of substrate in 1min
under the assay conditions using the reported extinction coeﬃcient
(εPhenol red at 550 nm=8450 M−1 cm-1) [51,52]. All values were
corrected for non-enzymatic transformation using as controls the sus-
pensions of the mesostructured silica and magnetic microparticles
without immobilized enzyme. Note that, using those control materials,
no appreciable (below detection limit; see [51]) hydrolysis was de-
tected for any of the tested esters.
The assay used to determine the substrate speciﬁcity and en-
antiospeciﬁcity is pH-based, which means that the pH of the reaction
solution changes as the substrates are hydrolyzed. As the immobiliza-
tion strategies are sensitive towards pH, we determined the pH change
during the course of the reactions to evaluate the risk of enzyme
Fig. 4. Schematic representation of the protocol used for
the synthesis of the NH2-SBA-15 mesostructured silica
support and EH1 immobilization. EH1 structure with the
cavity electrostatic surface, in red the negative charge and
in blue the positive charge, created with Maestro, is re-
presented. The access to the active site tunnel is indicated
with an arrow. The position of the Hig6-tag is highlighted
in yellow. Note that only one enzyme biomolecule is
visible in the entrance of the pores, but each cylindrical
pore channel could accommodate on average 26 enzyme
molecules arranged in a row along the channel.
Fig. 5. Schematic representation of the pro-
tocol used for the immobilization of EH1 on
two types of magnetic microparticles with dif-
ferent chemical and physical properties,
namely, agarose-coated ferromagnetic core-
shell microparticles in which EH1 was attached
through a NTA linker and polyvinyl alcohol
particles embedded with magnetite and grafted
with an IDA linker. By using Maestro, the po-
sition of the hexahistidine-tag in EH1 is high-
lighted in yellow, in blue (positive charge) and
red (negative charge) the residues conforming
the entrance to the active site, and in grey
color the rest of the protein. The access to the
active site tunnel is indicated with an arrow.
C. Coscolín et al. Applied Catalysis A, General 565 (2018) 59–67
63
leakage through pH change during the course of the reaction.
Additional details on the evaluation of pH change before, during and
after activity tests and their possible eﬀect of enzyme leaching from the
carriers, which was found below detection limit, are given in the
Supporting Information.
2.6. Structure analysis
The crystal structure of EH1 protein was recently solved and X-ray
diﬀraction data collection and reﬁnement statistics are available [51].
The Maestro interface (version 10.4) was used to provide structural
analysis.
3. Results and discussion
3.1. Substrate proﬁle and enantiospeciﬁcity of EH1 immobilized in NH2-
SBA-15
EH1, which was used as model enzyme was immobilized on the
amino-functionalized ordered mesoporous material NH2-SBA-15 (see
Experimental section and Fig. 4). The immobilized preparation, with
enzyme loads (48mg protein per gram of silica) in the range of pre-
viously reported studies [19,20], will be referred to as EH1SBA. The
hydrolytic activity of EH1SBA was evaluated relative to a set of 72 esters
hydrolyzed by free EH1 (see Experimental section). The immobilization
caused a signiﬁcant reduction in the substrate range (Fig. 6; Table S1)
as EH1SBA was only able to hydrolyze 17 esters, with cyclohexyl buty-
rate being the preferred substrate (5.3 ± 0.02 U mg−1). Thus, the
immobilization of the enzyme inside pores narrows the substrate scope.
Most likely, this signiﬁcant reduction of substrates may be a con-
sequence of the hydrophilic surface chemistry of the functionalized
mesoporous silica and of the limited access of molecules to the active
site when the enzyme is immobilized inside the pores, as it has been
previously observed for other enzymes [46,47]. However, the fact that
EH1SBA eﬃciently hydrolyzed large molecules such as phenyl acetate
and phenyl propionate, vinyl benzoate, benzyl 2-hydroxy-3-phenyl-
propionate, benzoic acid 4-formyl-phenylmethyl ester, 1-naphthyl
acetate, 1-naphthyl butyrate, and triglycerides (Fig. 6), suggests further
factors contributing to the substrate spectra of the ﬁnal enzymatic
preparation. Indeed, the partitioning coeﬃcient (LogP value) and the
molecular volume, which reﬂects electronic and steric eﬀects and hy-
drophobic and hydrophilic characteristics, revealed that esters being
hydrolyzed by EH1SBA ranged from LogP values of −0.19 to 3.85, and
molecular volumes of 115.37 to 297.46 Å3, respectively. However,
many other esters with similar values were not accepted as substrates
(Fig. 6; Table S1). Even very hydrophilic and small esters such as ϒ-
valerolactone (LogP: −0.27; volume: 96.74 Å3) and methyl lactate
(LogP: −0.72; volume: 98.57 Å3) were not hydrolyzed.
Focusing on stereochemistry, EH1 was capable of hydrolyzing 14
chiral esters, that is, (R) and (S) enantiomers of menthyl acetate, methyl
mandelate, ethyl 4-chloro-3-hydroxybutyrate, methyl 3-hydro-
xybutyrate, methyl 3-hydroxyvalerate, methyl lactate and ethyl lactate
(Fig. 6; Table S1). The Eapp for the free EH1, calculated as the ratio of
speciﬁc activity (U mg−1) of the preferred chiral ester over that of the
non-preferred one when both esters were tested separately [53,54],
ranged from 1.45 to 14.2 (Table 1). EH1SBA was capable of hydrolyzing
only 4 out of the 14 chiral esters for which the free EH1 showed ac-
tivity. Interestingly, the Eapp for ethyl (R)-4-chloro-3-hydroxybutyrate
over ethyl (S)-4-chloro-3-hydroxybutyrate (LogP: 0.33; volume:
145.95 Å3) increased from 1.45 for EH1 to 419 for EH1SBA. Slight in-
crease in the Eapp (2.6 vs 4.7 in the same order) was observed for ethyl
(R/S)-lactate (LogP: -0.19; volume: 115.37 Å3) (Table 1). Other chiral
esters with lower or higher LogP values and molecular volumes were
not accepted as substrates.
To conclude, the immobilization in NH2-SBA-15 caused not only a
signiﬁcant reduction of the substrate spectrum but also a signiﬁcant
increase in Eapp, particularly for ethyl (R)-4-chloro-3-hydroxybutyrate,
a chiral compound broadly appreciated for the synthesis of biologically
and pharmacologically important materials such as (R)-carnitine, (R)-4-
amino-3-hydroxybutyric acid, and (R)-4-hydroxy-2-pyrrolidone [61].
We further evaluated whether the observed changes in speciﬁcity and
Eapp of EH1 induced by the immobilization in NH2-SBA-15 were speciﬁc
or not for this support. Therefore, we immobilized EH1 on other car-
riers, i.e., magnetic microparticles, where the enzyme was chemically
Fig. 6. Substrate range of free EH1 and its immobilized preparations. The ID
code representing each variant is color coded. This Figure is created from data
given in Supporting Table S1. The classes of esters tested are indicated on the
left side. The Figure was created with the R language console using information
about the speciﬁc activity (units g−1) of the analyzed enzymes against the 72
substrates hydrolyzed by EH1 as a starting point. The activity protocol estab-
lished and used to identify the esters hydrolyzed by each EH1 variant was based
on a continuous pH indicator assay at pH 8.0 and 30 °C, performed in triplicate
and corrected for background signal (see Experimental section). The LogP va-
lues for each ester were calculated using the ACD/ChemSketch 2015.2.5 soft-
ware.
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linked to the surface of the support. Other carriers such as Celite® and
Sepabeads were used but the resulting preparations showed residual
activity and thus were not further considered in this study.
3.2. Substrate proﬁle and enantiospeciﬁcity of EH1 immobilized on
magnetic microparticles
EH1 was immobilized on two types of magnetic microparticles (see
Experimental section), namely, agarose-coated core-shell ferromagnetic
particles to which EH1 was attached through a NTA linker (referred to
as EH1NTA; Fig. 4), and PVA particles with embedded magnetite and
grafted with an IDA linker (referred to as EH1IDA; Fig. 5).
EH1IDA preparation has the ability to hydrolyze 60 substrates, with
phenyl acetate being the preferred ester (104.0 ± 0.13 U mg−1)
(Fig. 6; Table S1). EH1NTA hydrolyzed the same set of 60 substrates
hydrolyzed by EH1IDA plus ethyl benzoate, with also phenyl acetate
being the preferred ester (90.5 ± 1.8 U mg−1). Compared to the free
enzyme these preparations were unable to hydrolyze 11 esters, which
included methyl octanoate, methyl decanoate, ethyl decanoate, pentyl
benzoate, methyl 2-hydroxybutyrate, isobutyl cinnamate, phenethyl
cinnamate, isobutyl cinnamate, methyl 2,5-dihydroxycinnamate, men-
thyl acetate, and vinyl acrylate. None of these 11 esters were either
hydrolyzed by EH1SBA. All but vinyl acrylate (LogP: 0.38; volume:
96.07 Å3) could be considered as large hydrophobic esters (LogP: from
1.51 to 4.96; volume: from 136.59 to 244.4 Å3). However, other large
molecules with LogP values as high as 3.64 such as benzyl 4-hydro-
xybenzoate, and molecular volume as high as 338.38 Å3 such as glucose
pentaacetate, were hydrolyzed, suggesting again that factors others
than surface chemistry and substrate access limitations may contribute
to the substrate spectra of the ﬁnal enzymatic preparations EH1NTA or
EH1IDA. Following on from this, it should be mentioned that both
preparations showed similar substrate spectra, with a clear distinct
preference for alkyl esters. Indeed, whereas EH1NTA showed from 3 to
19-fold higher preference for short alkyl esters such as methyl butyrate,
ethyl propionate, ethyl butyrate, propyl acetate, propyl propionate,
propyl butyrate, and butyl acetate, EH1IDA preferred (from 1.4 to 5-
fold) longer esters such as methyl hexanoate, ethyl hexanoate, ethyl
octanoate, hexyl acetate, and octyl acetate (Table S1).
All esters hydrolyzed by EH1SBA were also hydrolyzed by EH1IDA
and EH1NTA, whereas the immobilization on the surface of magnetic
microparticles produced biocatalysts capable of converting 44 esters
which EH1SBA did not accept. These range from small hydrophilic esters
such as methyl glycolate (LogP: -1.07; volume: 81.98 Å3) to large hy-
drophobic esters such as vinyl laurate (LogP: 6.04; volume: 252.91 Å3).
With regards to stereochemistry, EH1IDA catalyzed the hydrolysis of
all those chiral esters hydrolyzed by the free enzyme except (R)-
(-)-menthyl acetate and (S)-(+)-menthyl acetate, which were not ac-
cepted as substrates (Fig. 6; Table S1). Interestingly, the Eapp for
(-)-methyl (S)-lactate over (+)-methyl (R)-lactate increased from∼4.6
for the free enzyme to∼194 for EH1IDA (Table 1). Similarly, the Eapp for
(-)-ethyl (S)-lactate over (+)-ethyl (R)-lactate increased from ∼2.6 to
∼154, in the same order. No signiﬁcant changes of the Eapp were ob-
served for the other chiral esters, including ethyl (R/S)-4-chloro-3-hy-
droxybutyrate for which the Eapp signiﬁcantly increased after im-
mobilization in NH2-SBA-15. EH1NTA was capable of hydrolyzing the
same set of chiral esters as EH1IDA (Fig. 4; Table S1), but a notable
diﬀerence was observed. Particularly, the Eapp for methyl (S)-
(+)-mandelate over methyl (R)-(-)-mandelate increased from ∼14.2
for the free enzyme to ∼150 for the EH1NTA preparation (Table 1),
substrates for which EH1IDA did not show any preference (Eapp approx.
1). No signiﬁcant changes of the Eapp were observed for the other chiral
esters.
In summary, immobilization on the surface of agarose-coated large
core-shell ferromagnetic microparticles (25–30 μm) through a NTA
linker slightly altered the substrate range (61 esters) while producing a
biocatalyst more selective for short alkyl esters and for methyl (S)-
(+)-mandelate. Moreover, immobilization on the surface of small
polyvinyl alcohol magnetic microparticles (1–5 μm) through an IDA
linker also slightly altered the substrate range (60 esters) while pro-
ducing a more selective biocatalyst for ethyl and methyl (S)-lactate and
slight preference for longer alkyl esters.
3.3. Flexibility constrains as determinants deﬁning chiral preference of
biocatalysts
Based on the crystal packing (PDB 5JD4) EH1 is a dimer [51], the
dimensions of that are approximately 70 Å×44 Å×42 Å (or 7 nm×
4.4 nm × 4.2 nm). Enzymes with these dimensions have been suc-
cessfully immobilized in large-pore size SBA-15 materials [38]. The
mesoporous silica used to immobilize EH1 possesses pore channels
which are about 200 nm long with a highly uniform diameter close to
9.3 nm (Figs. 2 and 3). The grafting of aminopropyl groups on the
surface of pores makes the actual pore width available for enzyme
immobilization even slightly smaller (ca. 2 nm). Therefore, it is ex-
pected that the cylindrical pore channels may accommodate only one
enzyme molecule along the channel diameter. Considering the enzyme
diameter (about 7 nm×4.4 nm× 4.2 nm) and the length (200 nm) and
diameter (9.3 nm for SAB-15 or ca. 7.3 nm for the amino funcionalized
material) of the channels, it follows that each cylindrical pore channel
could accommodate on average 26 enzyme molecules arranged in a row
along the channel, in which each enzyme molecule may have restricted
movement due to the similar size of enzyme structure and pores. Hence,
there will be very little space for substrate and product molecules to
diﬀuse in and out of the channels. Additional details on the enzyme
load and enzyme immobilization kinetics in the NH2-SBA-15 support
are given in the Supporting Information.
To investigate which zones of the negatively charged proteins may
most likely interact with the positively charged surface of the pores, a
surface electrostatic analysis of the EH1 structure was performed. The
analysis shows a negative zone around the binding cavity entrance
(Fig. 4), and thus it is plausible that the active site is oriented to the
surface of the amino-functionalized ordered mesoporous material. The
hindered movement of the enzyme inside the pores and the most likely
unfavorable orientation of the EH1 binding cavity may explain the re-
stricted substrate spectrum of the EH1SBA preparation. However, both
reasons per se do not explain the fact that the enzyme immobilized
inside the 7.3 nm diameter pores of NH2-SBA-15 materials retains the
capacity to hydrolyze some very large and hydrophobic molecules such
Table 1
Enantiospeciﬁcity of EH1 and immobilized preparations against a number of
chiral esters, as revealed by calculations of Eapp.
Estimated Eappb
Estera EH1 EH1SBA EH1IDA EH1NTA
1RS 9.65 ± 0.70 n.d n.d n.d
2RS 14.2 ± 0.46 n.d 0.95 ± 0.20 151 ± 1
3RS 1.45 ± 0.05 419 ± 9 3.58 ± 0.03 0.64 ± 0.24
4RS 4.89 ± 0.36 n.d 9.09 ± 0.20 3.16 ± 0.31
5RS 4.41 ± 0.04 n.d 3.12 ± 0.07 1.58 ± 0.29
6RS 2.60 ± 0.03 4.73 ± 0.17 154 ± 9 2.02 ± 0.17
7RS 4.56 ± 0.36 n.d 194 ± 2 1.45 ± 0.19
a Compounds ID: 1RS, (R/S)-menthyl acetate; 2RS: methyl (R/S)-mandelate;
3RS: ethyl (R/S)-4-chloro-3-hydroxybutyrate; 4RS: methyl (R/S)-3-hydro-
xybutyrate; 5RS: methyl (R/S)-3-hydroxyvalerate; 6RS: ethyl (R/S)-lactate;
7RS: methyl (R/S)-lactate; the preferred chiral ester is indicated underlined
and in bold.
b Eapp was calculated per each of the pairs of enantiomers as the ratio of
speciﬁc activity (U mg−1) per each of the 14 chiral esters when pure stereo-
isomers were tested separately, as described elsewhere [53,54]. These calcu-
lations were extracted from data in Table S1. n.d.: Activity not detected under
our assay conditions.
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as benzoic acid 4-formyl-phenylmethyl ester, while being unable to
hydrolyze very small esters such as vinyl acetate (Fig. 6). It is plausible
that factors others than access of molecules to the pores and to the
active site play an additional role in determining the substrate speci-
ﬁcity (including enantiospeciﬁcity). In this study we hypothesized that
protein immobilization could aﬀect not only the free movement of the
enzyme but also impose ﬂexibility constraints to the enzyme molecule.
Note that catalytic triads in serine ester hydrolases are located in a
catalytic environment where residues lining the active site are con-
tributing to binding and correct positioning of substrates [51,52]. Al-
tering the position, distances and angles of those residues may alter the
binding capacity. This may explain the binding preference of EH1SBA for
ethyl (R)-(-)-4-chloro-3-hydroxybutyrate over (S)-(+)-4-chloro-3-hy-
droxybutyrate.
To prove whether the ﬂexibility constraints may explain the im-
proved Eapp for ethyl (R)-(-)-4-chloro-3-hydroxybutyrate, EH1 was im-
mobilized in NH2-SBA-15 materials with same surface chemistry (1.6 or
1.4 mmol aminopropyl groups per gram of support) but wider pores
(pore diameter of 16.7 or 14.0 nm) (details on the synthesis and char-
acterization of these supports are given in the Supporting Information).
The speciﬁc activity of both preparations towards ethyl (R/S)-(-/+)-4-
chloro-3-hydroxybutyrate was determined, and the Eapp calculated. The
Eapp for EH1 immobilized in the material with a diameter of 16.7 nm
was found to be 4.51 (R preference), and 4.57 (R preference) for that
with 14.0 nm diameter. This value is slightly higher than that of the free
enzyme (∼1.5) but signiﬁcantly lower than that obtained when the
enzyme was immobilized in the material with pores of 9.3 nm diameter
(∼420) where EH1 has a tight ﬁt. These results suggest that restricting
the enzyme movement and/or promoting enzyme rigidity by non-
covalent enzyme immobilization in pores with diameters close to that of
the enzyme crystal packing may help promoting enantiospeciﬁcity.
In EH1NTA and EH1IDA a controlled immobilization via His-tag is
used. Immobilization of proteins through the His-tag allows an oriented
immobilization of all enzyme molecules, which is important to have a
clue about the accessibility of the active site cavity with respect to the
surface of the support. In this line, immobilization of the His-tagged
enzyme onto nickel(II)-cyclam grafted mesoporous silica have been
shown to allow tailored made adsorption [62] as this may avoid pro-
blems associated to an unfavourable orientation of the enzyme. An
analysis of the EH1 structure revealed that orientation of EH1 both in
EH1NTA and EH1IDA is favorable for the substrate access to the active
site tunnel. Indeed, the N-terminus of the enzyme where the His-tag is
located is oriented opposite to the active site cavity (Fig. 5). However,
this favorable orientation, which may occur in both preparations, does
not explain per se why the two immobilized preparations were not able
to hydrolyze 12 (EH1NTA) and 11 (EH1IDA) esters which were hydro-
lyzed by the free enzyme. These molecules included large esters such as
methyl octanoate, methyl decanoate, ethyl decanote, pentyl benzoate,
methyl-2-hydroxybenzoate, isobutyl cinnamate, methyl 2,5-dihydrox-
ycinnamate, phenylethyl cinnamate, and menthyl acetate, but also
short esters such as vinyl acrylate, which a priori should cause less
diﬀusional problems compared to larger esters. Also, it does not explain
that both preparations were able to hydrolyze methyl benzoate (LogP:
2.2; volume: 263.3 Å3) and vinyl benzoate (LogP: 2.25; 139.74 Å3),
whereas the slightly larger ethyl benzoate (LogP: 2.73; 145.38 Å3) was
only accepted by EH1NTA (Fig. 6; Table S1). Finally, it does not explain
the increased preference of EH1NTA for methyl (S)-(+)-mandelate
(LogP: 0.9; 153.42 Å3) or the increased preference of EH1IDA for ethyl
(S)-lactate (LogP: -0.72; 98.57 Å3) and larger alkyl esters. We hy-
pothesize that the stronger interaction of the protein through a NTA
linker in EH1NTA compared to IDA linker in EH1IDA may slightly in-
crease the rigidity of the protein and thus alter the entrance or posi-
tioning of a speciﬁc subset of esters, thus inﬂuencing substrate pre-
ference and speciﬁcity for speciﬁc set of esters, including chiral esters.
It is also plausible that the smaller particles may have a higher density
of proteins, which may aﬀect their packing on the surface.
4. Conclusion
In this manuscript we studied the eﬀect of immobilization of a
model enzyme in an unprecedented manner. Through an extensive
analysis of the substrate spectra, we examined in depth the contribution
of surface chemistry, particle size, substrate accessibility to the active
site tunnel, and ﬂexibility constraints, driven by each immobilization
strategy, on enzyme substrate speciﬁcity and stereochemistry. We
found that ﬂexibility constraints, which can be modulated through
careful materials design (particle size, pore size and architecture) and
functionalization (strength of the linkage), are among the most im-
portant factors determining the speciﬁcity and stereochemistry of im-
mobilized enzymes. These constraints may most likely aﬀect the en-
zyme structure and the active site conﬁguration and in turn the access
and positioning of substrates in the active site. This was herein proven
by converting an ester hydrolase with broad substrate spectrum but
non-enantiospeciﬁc, a common feature in natural esterases, into bio-
catalysts capable of converting speciﬁc molecules, including stereo-
isomers, depending on the immobilization strategy applied. Therefore,
by controlling the immobilization strategy, the size and the functiona-
lization of materials and interfaces employed, one can use substrate
promiscuous enzymes to design biocatalysts for multiple selective cat-
alytic routes and stereochemistry, and to produce a range of chiral
molecules which are important building blocks for drug/fragrance
discovery, chemical biology, and modern materials science. Finally, the
present study suggests that a controlled manipulation of speciﬁcity of
enzymes can be achieved to a higher extent than previously envisaged
by size/chemistry-tunable materials, to produce more eﬃcient cata-
lysts. Studying mesoporous materials with a large constellation of pore
sizes and materials with diﬀerent density of reactive groups may be of
interest in the future to obtain a clue about their impact in enzyme
rigidity/ﬂexibility and to design carriers with characteristics capable of
producing a desired change in substrate speciﬁcity or stereochemistry.
Investigation of immobilization eﬀect by computational methods will
help deepening into the structural constrains induced by diﬀerent car-
riers, the quantiﬁcation of the rigidity/ﬂexibility, and its link with
speciﬁcity (see additional comments in Supporting Results).
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